Advanced Search

Treatment Of Acute Myeloid Leukemia Stocks List

Symbol Grade Name % Change
BLRX B BioLineRx Ltd. -6.19
FBIO D Fortress Biotech, Inc. -0.32
CTIC C Cell Therapeutics, Inc. 2.88
APTO F Aptose Biosciences, Inc. -1.14
SLS D SELLAS Life Sciences Group, Inc. -3.31
CGEM F Cullinan Management, Inc. -2.17
HCWB D HCW Biologics Inc. -3.65
View As Page of Charts
Related Industries: Biotechnology Other
Related Stock Lists: Acute Myeloid Leukemia Cancer Clinical Medicine Biopharmaceutical Medicine Oncology Solid Tumors Autoimmune Disease Autoimmune Diseases Biotechnology Breast Cancer Cancer Treatments Clinical Development Hematologic Malignancies Immune System Immunology Immunotherapies Immunotherapy Ovarian Cancer Treatment Of Breast Cancer

Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Acute Myeloid Leukemia stocks.

Symbol Grade Name Weight
SBIO F ALPS Medical Breakthroughs ETF 0.19
IWC C iShares Microcap ETF 0.11
VFLQ B Vanguard U.S. Liquidity Factor ETF 0.06
IWN C iShares Russell 2000 Value ETF 0.02
IWM C iShares Russell 2000 ETF 0.02
View all Treatment Of Acute Myeloid Leukemia ETFs...
Compare ETFs
  • Compare IWC to IWM
  • Compare IWC to IWN
  • Compare SBIO to VFLQ

    • Recent Signals

    Date Stock Signal Type
    2021-08-04 APTO New 52 Week Closing Low Bearish
    2021-08-04 BLRX Fell Below 20 DMA Bearish
    2021-08-04 BLRX 50 DMA Support Bullish
    2021-08-04 BLRX New Downtrend Bearish
    2021-08-04 BLRX Bollinger Band Squeeze Range Contraction
    2021-08-04 BLRX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-08-04 CTIC Bollinger Band Squeeze Range Contraction
    2021-08-04 CTIC MACD Bullish Centerline Cross Bullish
    2021-08-04 CTIC Pocket Pivot Bullish Swing Setup
    2021-08-04 FBIO 20 DMA Resistance Bearish
    2021-08-04 FBIO Bollinger Band Squeeze Range Contraction
    2021-08-04 HCWB Hot IPO Pullback Bullish Swing Setup
    2021-08-04 SLS Fell Below 20 DMA Bearish
    2021-08-04 SLS Bollinger Band Squeeze Range Contraction

    Treatment Of Acute Myeloid Leukemia Stocks Recent News

    Date Stock Title
    Aug 4 APTO Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2021 Results - Earnings Call Transcript
    Aug 3 APTO Aptose Biosciences EPS beats by $0.04
    Aug 3 APTO Aptose Reports Results for the Second Quarter 2021
    Aug 2 FBIO Fortress Biotech (FBIO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
    Aug 2 APTO Is a Beat in Store for Zoetis (ZTS) This Earnings Season?
    Aug 2 FBIO Mustang Bio Receives European Medicines Agency PRIME Designation for MB-107 to Treat X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
    Aug 2 APTO We Think Aptose Biosciences (TSE:APS) Can Afford To Drive Business Growth
    Aug 1 CTIC The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
    Aug 1 APTO The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
    Jul 29 CTIC CTI BioPharma to Report Second Quarter 2021 Financial Results on August 5, 2021
    Related Industries: Biotechnology Other
    Related Stock Lists: Acute Myeloid Leukemia Cancer Clinical Medicine Biopharmaceutical Medicine Oncology Solid Tumors Autoimmune Disease Autoimmune Diseases Biotechnology Breast Cancer Cancer Treatments Clinical Development Hematologic Malignancies Immune System Immunology Immunotherapies Immunotherapy Ovarian Cancer Treatment Of Breast Cancer

    Browse All Tags